LLG 88
Alternative Names: LLG88Latest Information Update: 06 Aug 2004
At a glance
- Originator Unknown
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 06 Aug 2004 Discontinued - Preclinical for Alzheimer's disease in Italy (unspecified route)
- 11 Aug 2003 Preclinical trials in Alzheimer's disease in Italy (unspecified route)